期刊文献+

年龄 性别对肾素-血管紧张素系统的近日节律的影响 被引量:1

Effects of age and sex on circadian rhythms of renin-angiotensin system.
原文传递
导出
摘要 目的探讨年龄、性别对肾素-血管紧张素系统(RAS)的近日节律的影响。方法将96只 SD 大鼠按年龄和性别分为3组,分别检测大鼠血中肾素(Ren)、血管紧张素Ⅱ(AngⅡ)、血管紧张素转换酶(ACE)的浓度或活性。结果成年雄性组的 Ren、ACE、AngⅡ显著高于老龄雄性和雌性组。老龄雄性和雌性组间3种物质差异无显著性意义。3组大鼠的 Ren、ACE、AngⅡ均呈现典型的近日节律(P<0.05)。结论大鼠 RAS 的活性随年龄增长而降低,性别对老龄大鼠 RAS 的活性无显著影响。老龄大鼠组 Ren、ACE、AngⅡ的昼夜波动幅度较成年大鼠组减小。 Objective To study the effect of age and sex on circadian rhythms of renin-angiotensin system(RAS) .Methods 96 SPRD rats were divided into three groups.The levels of renin(Ren)activity,angiotensin Ⅱ(Ang Ⅱ)and angiotensin-converting-enzyme(ACE)in plasma or serum were respectively determined.Results The plasma or serum levels of renin,ACE,and angiotensin-Ⅱ in adult male group(D group)were significantly increased in comparison with elderly male group(M group)and elderly female group(F group).There were not significantly different between F group and M group in the levels of Ren activity,AngⅡ and ACE.The three substances presented typical circadian rhythms in three groups(P<0.05).Conclusion The activity level of the renin-angiotensin system of rats decreased as the ageing increased.There was no significant effect on elderly rats for different sex.The vibration amplitude in both M group and F group were decreased,which suggested that the oscillations of plasma and serum level of renin activity,ACE and angioten- sin Ⅱ were attenuated in elderly rat group than adult rats.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2007年第S2期13-15,共3页 Chinese Journal of Practical Internal Medicine
关键词 近日节律 肾素-血管紧张素系统 肾素 血管紧张素转换酶 血管紧张素Ⅱ Circadian rhythm Benin-angiotensin system Renin Angiotensin-convertion enzyme
  • 相关文献

参考文献12

  • 1Yi-Fang Guo,Phyllis K. Stein.Circadian Rhythm in the Cardiovascular System: Considerations in Non-Invasive Electrophysiology[J]. Cardiac Electrophysiology Review . 2002 (3)
  • 2Nonaka,H,Emoto,N,Ikeda,K,Fukuya,H,Rohman,MS,Raharjo,SB,Yagita,K,Okamura,H,Yokoyama,M.Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells. Circulation . 2001
  • 3Yoshimura T,Yasuo S,Suzuki Y,et al.Identification of the suprachiasmatic nucleus in birds. American Journal of Physiology . 2001
  • 4Watson RD,,Stallard TJ,Flinn RM, et al.Factors determining direct arterial pressure and its variability in hypertensive man. Journal of Hypertension . 1980
  • 5Korkusko OV,,Kalinovskaja EG,Asinova MI.Change in the renin-angiotensin-aldosterone system in aging. ZFA . 1987
  • 6Dean SA,Tan J,O‘Brien ER, et al.17beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. American Journal of Physiology Regulatory . 2005
  • 7Dean SA,Tan J,White R, et al.Regulation of components of the brain and cardiac renin-angiotensin systems by 17{beta}-estradiol following myocardial infarction in female rats. American Journal of Physiology Regulatory . 2006
  • 8Mercedes L.Estrogen, natriuretic peptides and the reninangiotensin system. Cardiovascular Research . 1999
  • 9Kawasaki T,,Cugini P,Uezono K. et al.Circadian variations of total renin, active renin, plasma renin activity and plasma aldosterone in clinically healthy young subjects. Hormone and Metabolic Research . 1990
  • 10LEMMER B,WITTE K,SCHANZER A,et al.Circadian rhythms in the renin-angiotensin system and adrenal steroids may contribute to the inverse blood pressure rhythm in hypertensive TGR(mREN-2)27 rats. Chronobiology International . 2000

同被引文献17

  • 1Banks WA, Willoughby LM, Thomas DR, et al. Insulin resist- ance syndrome in the elderly : assessment of functional, biochemical, metabolic, and inflammatory status. Diabetes Care 2007 ; 30 ( 9 ) :2369 - 2373.
  • 2Janke J, Engeli S, Gorzelniak K, et al. Mature adipocytes in- hibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 2002;51(6) :1699 -1707.
  • 3Thatcher S, Yiannikouris F, Gupte M, et al. The adipose renin- angiotensin system:role in cardiovascular disease. Mol Cell Endocrinol 2009 ;302(2) :111 -7.
  • 4Zhou MS, Schulman IH. Prevention of diabetes in hyperten- sive patients: results and implications from the VALUE trial. Vasc Health Risk Manag 2009 ;5 ( 1 ) :361 - 368.
  • 5Shao J, Iwashita N, Ikeda F, et al. Beneficial effects of cande- sartan,an angiotensin II type 1 receptor blocker, on beta-ceU function and morphology in db/db mice. Biochem Biophys Res Commun 2006;344(4) :1224 - 1233.
  • 6Huang Z, Jansson L, Sjnholm A. Vasoactive drugs enhance pancreatic islet blood flow, augment insulin secretion and improve glu- cose tolerance in female rats. Clin Sci (Lond) 2007 ; 112 ( 1 ) : 69 - 76.
  • 7Kraus D, Jager J, Meier B, et al. Aldosterone inhibits uncoup- ling protein-1 ,induces insulin resistance, and stimulates proinflammato- ry adipokines in adipocytes. Horm Metab Res 2005 ; 37 ( 7 ) .. 455 - 459.
  • 8Lindholm LH, Ibsen H, Borch-Johnsen K, et al. Risk of new- onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. Journal of hypertension 2002 ; 20 ( 9 ) : 1879 - 1886.
  • 9Julius S, Kjeldsen SE ,Weber M, et al. Outcomes in hyperten- sive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. The Lancet 2004 ;363 (9426) :2022 - 2031.
  • 10Effects of ramipril on cardiovascular and microvascular out- comes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000 ;355 (9200) :253 - 259.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部